SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-17-015859
Filing Date
2017-09-12
Accepted
2017-09-12 16:03:04
Documents
19
Period of Report
2017-10-26
Effectiveness Date
2017-09-12

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A tech20170908_def14a.htm DEF 14A 1519687
2 proxy2.jpg GRAPHIC 156784
3 proxy1.jpg GRAPHIC 197038
4 a16.jpg GRAPHIC 20698
5 a5.jpg GRAPHIC 761
6 a15.jpg GRAPHIC 9941
7 a14.jpg GRAPHIC 11175
8 a13.jpg GRAPHIC 9695
9 a12.jpg GRAPHIC 9797
10 a11.jpg GRAPHIC 11095
11 a10.jpg GRAPHIC 10624
12 a9.jpg GRAPHIC 10815
13 a8.jpg GRAPHIC 11064
14 a7.jpg GRAPHIC 9949
15 a6.jpg GRAPHIC 11268
16 a4.jpg GRAPHIC 2495
17 a3.jpg GRAPHIC 11237
18 a1.jpg GRAPHIC 2244
19 a2.jpg GRAPHIC 6133
  Complete submission text file 0001437749-17-015859.txt   2212086
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

IRS No.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-17272 | Film No.: 171081135
SIC: 2836 Biological Products, (No Diagnostic Substances)